Skip all navigation Skip to page navigation

DHHS Home | A-Z Site Map | Divisions | About Us | Contacts |

NC Department of Health and Human Services
Women's and Children's Health Home
N.C. Public Health Home
North Carolina Immunization Branch

North Carolina Immunization Branch

The N.C. Immunization Branch promotes public health through the identification and elimination of vaccine-preventable diseases like polio, hepatitis B, measles, chickenpox, whooping cough, rubella (German measles), and mumps. In 2001, the Branch incorporated an adult education component into the program to raise awareness of the agelessness of immunizations.

Hot Topics
  • Epidemiology and Prevention of Vaccine-Preventable Diseases - Nov 1-3, 2017: The Centers for Disease Control and Prevention (CDC) will be in North Carolina providing 3 immunization courses. Designed for anyone seeking the most comprehensive and current knowledge of immunization, including physicians, nurses, medical assistants, pharmacists, immunization providers, program managers, and nursing and medical students. Details are located here.
  • State Immunization Conference: Wednesday, July 19 - Friday, July 21 2017 at the Joseph S. Koury Convention Center, Greensboro. This year’s conference fee is $110 per participant. Registration is now open, please register here!
  • 2017 Katz Award: Recognizing outstanding accomplishments in immunization strategies, projects or programs to increase immunization coverage rates. One winner will receive a waived conference registration fee and accommodations for 2 nights on July 19 - 20, 2017 at the Sheraton Greensboro Hotel at Four Seasons for the 2017 Immunization Conference.

    Applications must be received by Friday, May 12, 2017. Completed nomination packets should be submitted to: Nikki Barbour, Immunization Branch 1917 Mail Service Center Raleigh, NC 27699-1917. (May, 1, 2017)
  • CDC Health Care Professional Childhood Schedule Website Update: The CDC update impacts footnote language of birth-dose monovalent HepB vaccines for newborns. View here (March, 16, 2017)
  • Flu: FluLaval is now approved for use in persons aged 6 months and older. For more guidance on this recommendation please click here. (January 12, 2017)
Frequently Requested
News and Events